Through our analysis of public data regarding the GEO, TCGA, and CPTAC (Clinical Proteomic Tumor Analysis Consortium) databases, the results show that both mRNA and protein levels of NEDD4L were decreased in patients with lung cancer (Figure S5C–F). This evidence concerns the gene NEDD4L and neoplasm.